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ScienceDirectIn the lymph node, T cells migrate rapidly and with striking
versatility in a continuous scan for antigen presenting dendritic
cells. The scanning process is greatly facilitated by the lymph
node structure and composition. In vivo imaging has been
instrumental in deciphering the spatiotemporal dynamics of
intranodal T cell migration in both health and disease. Here we
review recent developments in uncovering the migration
modes employed by T cells in the lymph node, the underlying
molecular mechanisms, and the scanning strategies utilised by
T cells to ensure a timely response to antigenic stimuli.
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Introduction
The remarkable migratory skills of T lymphocytes are
central to the immunosurveillance of tissues and the
development of adaptive immunity against infection
and cancer. Antigen-inexperienced ‘naı¨ve’ T cells are
continuously trafficking between the vasculature and
lymph nodes (LNs) in search of cognate antigen [1]
The LN, a multifunctional and compartmentalised organ,
brings antigen-loaded dendritic cells (DC) and a large
number of scanning T cells in proximity. Upon antigen
encounter on DCs, naı¨ve T cells can be primed into an
‘effector’ state, ready to exert their cytotoxic, helper or
regulatory function in pathogen-laden or neoplastic tis-
sues (reviewed in [2]). Both naı¨ve and effector T cells
possess a cell-intrinsic aptitude for tissue scanning, yet in
the crowded landscape of the LN, their migration is in
addition governed by an array of extrinsic biomechanical
cues. Accordingly, the architecture and composition ofwww.sciencedirect.com the LN collectively shape a guidance structure that is
fundamental for optimal T cell scanning. Recent
advances in intravital multiphoton microscopy (IVMM)
modalities have allowed unprecedented insight into the
complex migratory behaviour of T cells within the lym-
phoid microenvironment. In this review, we use T cell
locomotion in the LN as a paradigm to understanding in
vivo leukocyte motility. We discuss the cellular and
molecular mechanisms that govern their motility in the
LN both in the steady state and during inflammation.
Migration mode of T cells in vivo
T cells are highly versatile migrators and can effectively
navigate almost any tissue of the body. As other leukocytes,
T cells migrate using an ‘amoeboid’ mode of locomotion in
three-dimensional in vivo environments [3]. The amoe-
boid migration of T cells is characterised by a rounded yet
polarised morphology. Frequent and rapid extensions of
pseudopodia at the leading edge are driven by the polymer-
isation of filamentous actin (F-actin) that extends the
plasma membrane in the direction of migration
(Figure 1) [4]. In contrast, stable F-actin networks rich
in myosin motors characterise the uropod, a lagging tail that
undergoes little overall deformation [5]. T cells can rapidly
alternate between adhesion-dependent and adhesion-
independent motility in order to adapt to the varying tissue
architecture and molecular composition of their surround-
ing. In non-adhesive environments, leading edge pseudo-
podia are ‘wedged’ into confined spaces in the extracellular
matrix (ECM), which, coupled with actomyosin contrac-
tion of the rear, allows for a concerted translocation of the
cell [4,6,7]. During adhesion-driven migration, nascent
integrin-mediated attachments in the extended pseudo-
podia anchor the cell to the substrate. The retrograde flow
of treadmilling actin filaments coupled to the ECM sub-
sequently drives forward displacement of the cell [8]. The
contractile uropod is also adherent, albeit only loosely, and
actomyosin-mediated forces help detach mature adhesion
sites and propel the cell body forward (Figure 1). This
distal contractility is however partly dispensable in the LN,
as shown by both pharmacological inhibition [7] and con-
ditional knockout [9] of myosin function, upon which T
cells migrated suboptimally with an elongated shape, at
slower speeds and with less directionality. Surprisingly, it
was found that in T cells, actomyosin contractility is mainly
required for de-adhesion from the ECM rather than to
facilitate the passage of the rigid nucleus through the dense
lattices found in the LN [7], in stark contrast to what has
been observed for DCs [10]. Blocking antibodies and
genetic knockout models demonstrated that adhesion,
mainly mediated via the integrin LFA-1 and its ligand
ICAM-1, is not absolutely required for T cell motility, butCurrent Opinion in Cell Biology 2014, 30:17–24
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GLOSSARY BOX 1: Modes of chemokine-driven migration
Chemokinesis: non-directed migration in response to soluble
chemokines.
Haptokinesis: non-directed motility supported by immobilised
chemokines.
Chemotaxis: guided motility following a soluble chemokine gradient.
Haptotaxis: directed adhesive migration following a gradient of
substrate-bound chemokines. Although available in vivo evidence
strongly supports that T cells employ haptotaxis within the LN,
haptotactic guidance remains to be formally demonstrated.is essential for optimal intranodal scanning [6,7,11,12,13].
Consistently, targeted deletion of the LFA-1 adaptor
protein Kindlin-3 did not fully abrogate T cell migration
[14]. LFA-1 was however shown to promote T cell reten-
tion in the LN and thus prevents premature termination of
scanning [12]. Taken together, T cells migrate predomi-
nantly in a weakly adhesive and contractile mode where
integrin activity must be tightly regulated to generate
enough traction without compromising speed, and where
posterior actomyosin contractility facilitates propulsion of
the uropod. However, T cells are endowed with sufficient
redundancy to overcome the lack of both actomyosin
contractility and integrin-mediated adhesiveness during
migration.
Molecular mechanisms of T cell migration in
the LN
Intranodal T cell migration is dependent on signalling
mediated by G protein-coupled receptors (GPCRs), and
their Gia subunits (Figure 1), as shown by the reduction in
speed and displacement observed following pertussis toxin
(PTX, a Gia-specific inhibitor) treatment [15–17]. Binding
of the GPCR CCR7 by its ligands CCL19 and CCL21
stimulates the migratory behaviour of T cells within the
LN paracortex, principally by promoting high-speed moti-
lity [15,18]. However, while the absence of CCR7 signal-
ling resulted in only a partial reduction in motility,
inhibition of Gia by PTX induced a more pronounced
migratory defect [15,16]. Investigation of alternative che-
mokine axes such as CXCR4/CXCL12 and lipid mediators
have revealed only partial contributions to intranodal T cell
motility (reviewed in [19]), indicating the involvement of
as yet undiscovered GPCRs.
Ligand binding to GPCRs triggers signalling cascades
that govern cytoskeletal dynamics, polarity establishment
and motility via GTPases of the Rho or Rap families
(reviewed in [20,21]). In T cells, the Rho-GTPase Rac
polarises to the leading edge, where it stimulates Arp2/3
complex-driven branched actin network formation and
the expansion of pseudopodia (Figure 1). Abrogation of
Rac function, either via double knockout of Rac1 and
Rac2 [22] or via deletion of its upstream activator
DOCK2 [23], led to acute migratory defects in the
LN. Rac-deficiency had a more severe effect than che-
mokine depletion alone [22], highlighting the central
role of Rac-mediated signalling downstream of GPCRsCurrent Opinion in Cell Biology 2014, 30:17–24 and an additional cell-intrinsic role in T cell migration.
Rac1 and Rac2 were moreover shown to be functionally
redundant, as single knockout of either isoform did not
significantly alter the migration characteristics of T cells
[22]. Downstream of Rac, the ezrin-radixin-moesin
(ERM) proteins, concentrated in the uropod, link the
plasma membrane to the actomyosin cortex and modulate
T cell polarisation and migration through regulation of
cortical tension and by restricting protrusion formation to
the leading edge [24,25] (Figure 1). Expression of a
constitutively active form of ezrin in T cells resulted in
a limited ability to undergo shape changes, restricted
lamellopodia formation and a marked defect in intranodal
migration [25]. Another regulator of actin remodelling is
the actin binding protein Coronin 1A, an inhibitor of
Arp2/3 activity. A mutation in Coronin 1A that prevents
its recruitment to the leading edge results in dysmorphic
and often oversized anterior protrusions in T cells. Strik-
ingly, Coronin 1A mutant cells displayed slower and less
directional intranodal migration than their wildtype
counterparts [26]. These studies reveal that both exces-
sive and insufficient Rac-activity and Arp2/3-activity at
the leading edge lead to defective motility, underlining
the tight spatiotemporal regulation of F-actin dynamics in
migrating T cells.
The GTPase Rap1 and its effectors RAPL and Mst1
kinase are also necessary for effective intranodal T cell
migration [17]. Rap1 initiates chemokine-induced cell
polarisation by mediating the activation of Cdc42 and
Rac [27]. In vivo imaging studies revealed that RAPL [17]
and Mst1 [28] knockout T cells failed to establish a
polarised shape and displayed a significant reduction in
speed and displacement within the LN, comparable to
GPCR inhibition but more severe than integrin blockade.
These studies demonstrate that cytoskeletal and morpho-
logical polarisation are essential for intranodal T cell
migration.
GPCRs and T cell receptors (TCR) also signal to down-
stream phosphoinositide 3-kinase (PI3K) [29], an enzyme
that catalyses the phosphoinositide conversion required
for the plasma membrane recruitment and assembly of
signalling complexes such as the Rac activator DOCK2
[21,29]. In contrast to the better-known function of PI3K
signalling in other leukocytes [30], the contribution of
PI3K to intranodal T cell migration remains incompletely
understood and somewhat controversial. In one study,
pharmacological PI3K inhibition with Wortmannin and
genetic deletion resulted in slower motility with no
effects on other migratory parameters [31]. On the other
hand, T cells lacking the PI3Kg isoform, displayed
reduced directionality but no observable differences in
speed [23]. Yet a third in vivo imaging study in LN slices
reported that PI3K did not contribute to intranodal T cell
motility, as shown by Wortmannin treatment [32]. The
reasons for these conflicting reports could be attributablewww.sciencedirect.com
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Signalling pathways in intranodal T cell migration in vivo. Schematic representation of a polarised T cell during migration. Migrating T cells are
characterised by a protruding leading edge and a contractile lagging uropod. (Top insert) Chemokine binding to GPCRs in the pseudopodia triggers
localised Rap/RAPL signalling, Rac activation, and the formation of nascent integrin adhesion sites. In parallel, PI3K contributes to Rac activation via
DOCK2. Rac drives Arp2/3-mediated branched actin network formation, membrane protrusion and pseudopod extension. Coronin 1A binds to and
inhibits Arp2/3-driven actin polymerisation. (Bottom insert) Enrichment of activated ERM (ezrin-radixin-moesin) proteins in the uropod reinforce
membrane-cortex attachments to increase cortical stability and prevent posterior protrusions. Rho, via its effector kinase ROCK, activates myosin IIA-
mediated actomyosin contraction. The contractile forces generated serve to disengage the integrin clutch linking the cortex to the extracellular
environment during adhesion (dotted arrows), and propel the trailing end forward.to differences in experimental models, T cell subsets with
different requirements for PI3K signalling, and functional
redundancy among PI3K isoforms [29].
T cell scanning of the LN
IVMM observations have revealed that T cells move
constitutively, rapidly and randomly throughout the para-
cortex with variable speeds that average 10–12 mm/minwww.sciencedirect.com (reviewed in [33]). T cells migrate in a ‘stop-and-go’
pattern characterised by sudden bursts of high-speed
directional locomotion (‘runs’), followed by short
migratory arrests or slow confined movement during
which T cells interact with the stroma and other leuko-
cytes (Figure 2b) [34,35]. The onset of such transient
arrests and slower motility intervals are accompanied by
intermittent, low amplitude intracellular Ca2+ spikes in aCurrent Opinion in Cell Biology 2014, 30:17–24
20 Cell adhesion and migrationsubset of T cells in the LN [32,36]. It is becoming
increasingly clear that the magnitude and duration of
Ca2+ bursts directly influence the basal speed of T cell
motility in the LN. However, the mechanisms linking
Ca2+ signalling to cytoskeletal remodelling and ensuing
adjustments to T cell locomotion are still incompletely
understood (reviewed in [37]). It remains to be demon-
strated whether the spatiotemporal dynamics of intra-
cellular Ca2+ flickers govern T cell velocity and
steering in the LN, as has recently been shown in other
cell types in vitro (reviewed in [38]). T cells maintain their
amoeboid front-rear polarisation while engaging in brief
asymmetric contacts with DCs [39]. It is still unclear
whether this stop-and-go behaviour is the result of
obstacle collision or due to intrinsic cellular cues, or a
combination of both [40]. The frequency and duration of
probing interactions between T cells and other immune
cells greatly influence their overall scanning speed. In the
absence of cognate antigen, the fast basal motility of T
cells together with actively probing DCs is estimated to
result in a contact frequency of 100 different DCs/hour
for a single scanning T cell [41]. Initial IVMM studies
proposed a cell-intrinsic and autonomous behaviour that
fitted the ‘random walk’ model of particle diffusion
(reviewed in [42]). However, subsequent imaging studies
revealed that lymphocyte motility in vivo is highly de-
pendent upon local environmental cues, giving way to the
concept of guided random migration [18,43,44].
Guidance of T cell migration in the LN
The paracortex is constituted by a scaffold of ECM
conduits ensheathed by fibroblastic reticular cells
(FRC) (reviewed in [45]). This structure is interspersed
with DCs and forms the FRC network, an intricate
transportation grid that supports efficient T cell migration
and scanning, as well as entry into the paracortex via high
endothelial venules (HEV) (Figure 2a) [43,46,47].
FRCs produce the chemokines CCL19 and CCL21
(reviewed in [19]), which contribute to the spatial segre-
gation of the cortex into T and B cell zones by supporting
T cell migration only within the paracortex [15,18] and
guiding the penetration of lymph-derived T cells into the
deep T cell zone [48].
T cells migrate differently in different areas of the LN.
For example, T cells move slower in the medulla and the
subcapsular region than in the paracortex (Figure 2)
[18,23]. Such variety in migratory behaviours is likely
due to differences in the distribution and availability of
chemokinetic/haptokinetic stimuli (Glossary Box 1)
[15,18], and structural and physiological particularities
of each LN compartment [16]. Moreover, CD4+ T cells
recirculate more rapidly and spend shorter periods in each
LN (12 h) than their CD8+ counterparts (21 h) [49].
Contrary to CD8+ T cells, CD4+ T cells rely on the
presence of major histocompatibility complex (MHC)Current Opinion in Cell Biology 2014, 30:17–24 molecules on the surface of DCs to maintain an optimal
scanning mode [49].
Scanning in the presence of cognate antigen
Upon antigenic encounter, T cells alter their movement.
They initially display restricted motility, followed by
migratory arrest and stable engagements, and finally a
phase of dissociation and resumption of migration [50,51].
Reduction in motility and arrest are triggered by a ‘stop-
signal’, which enables the thorough probing and cellular
engagement with antigen-loaded DCs [52]. This antigen-
mediated stop signal is associated with higher frequency
and amplitude Ca2+ spiking than what has been observed
during homeostatic T cell scanning [36]. The presence of
suppressive regulatory T cells interferes with the stop-
signal and promotes motility upon cognate encounter,
mainly by hampering antigen recognition [53–57]. In
addition, the cytotoxic lymphocyte-associated antigen-4
(CTLA-4) and the program-death receptor 1 (PD-1) are
negative regulators of T cell activation that act partly by
blocking the stop-signal and promoting cell migration in
the presence of antigen [58,59]. However, while PD-1
blockade in T cells resulted in the restoration of the stop-
signal and reduced displacement, CTLA-4 inhibition did
not [59]. Comparison of conventional and regulatory T
cells revealed that the latter were partially resistant to
CTLA-4-mediated perturbation of the stop-signal [60],
highlighting the heterogeneity of signals that govern the
migratory behaviour of different T cell subsets.
T cell mobilisation to specific LN microenvironments
during priming provides an additional layer of regulation,
contributing to phenotypic differentiation and functional
outcome [61,62,63]. The CCR5 ligands CCL3 and
CCL4, and the CXCR3 ligands CXCL9, CXCL10 and
CXCL11, are produced in response to infection or injury
and promote the recruitment of immune mediators to the
site of inflammation (reviewed in [63]). These chemo-
kines have been shown to facilitate cognate encounter by
biasing T cell mobilisation towards antigen-loaded DCs
in the LN [44,61,64,65]. Activated T cells engage anti-
gen-presenting DCs, ‘licensing’ them to produce CCL3
and CCL4, thus attracting more naı¨ve T cells, which
during inflammation upregulate CCR5 (Figure 2c) [44].
Similarly, CXCR3 mediates intranodal recruitment of T
cells to the site of antigen accumulation (interfollicular
and medullary zones) for effective activation by
CXCL10-producing DCs [61,62] (Figure 2d). CXCR3-
mediated mobilisation is more efficient for memory than
for naı¨ve T cells [62].
Recent IVMM studies in infectious models in the LN
revealed a cellular immune network consisting of a wide
variety of leukocytes including CD8+ T cells, strategically
positioned near the periphery of the LN and pathogen-
sensing phagocytes [63]. Upon infectious challenge,
effector memory CD8+ T cells are rapidly recruited fromwww.sciencedirect.com
T cell migration Munoz, Biro and Weninger 21
Figure 2
Folicules
(B cell zone)
Paracortex
(T  cell zone)
HEV
Medula ry
sinuses
Cortical
sinuses 
Medulla
Subcapsular
sinus (SCS)
Efferent
lymphatic
vessel
Afferent
lymphatic
vessel 
Random  Guided  Migration
homeostatic chemokines
Guidan ce  by inflamm atory 
chemokines 
 
 The  Lymph Node
Reticular
conduits
naive T  cell
DC
CCL3/ CCL4
CCR5/nai ve T  cell
effector  T  cell 
Licensed DC
SCS Mac
Virion
Guidan ce  by flinammat ory
chemokines during in fection
Helper
T cell
CCR5/nai ve
T cell
Effector
T cell
Naive
T cell
SC mac
FRC
DC
FRC
CXCL9/C XCL10
Licen ced
DC
CCL19
CCL21
T cell mi gration p ath
FRC ne twork
(d) (c)(b)
(a)
Current Opinion in Cell Biology
Lymph node structure and migratory behaviour of T cells within the T cell zone. (a) Simplified diagram of the lymph node structure depicting the cortex
(pink) encased by the capsule. The cortex is subdivided into paracortex and B cell follicles. Each paracortical region is infiltrated by a high endothelial
venule (HEV). The subcapsular sinus (SCS), a space separating the capsule from the cortical parenchyma, collects the lymph from afferent lymphatics
and delivers it to the medullary region and the efferent lymph vessel. The medulla is rich in lymphatic endothelial structures called medullary sinuses
that penetrate the paracortex to become cortical sinuses. Grey arrows illustrate the flow of the lymphatic fluid within the lymph node. (b) The
paracortex is irrigated with ultrafiltrate lymph by an intricate scaffold of reticular conduits composed mainly of collagen fibres (clusters of black lines)
ensheathed by fibroblastic reticular cells (FRC, blue) that collectively form the FRC network. DCs are incorporated into the FRC network providing an
optimal transportation and scanning platform that ‘guide’ random basal T cell migration. T cell motility in the steady-state is stimulated by soluble
CCL19 and immobilised CCL21. The red dashed line indicates the random stop-and-go migratory behaviour of T cells. (c) T cells ‘license’ an antigen-
loaded DC to produce CCL3 and CCL4 and promote the recruitment of other CCR5-expressing naı¨ve T cells. Dashed line depicts the directional
migratory behaviour of T cells in response to inflammatory chemokines. (d) Lymph-borne infectious particles are captured by strategically positioned
SCS macrophages, which in turn trigger an inflammatory response that results in the fast and directional recruitment of effector T cells (dashed line) [4].
www.sciencedirect.com Current Opinion in Cell Biology 2014, 30:17–24
22 Cell adhesion and migrationthe deep paracortex towards the periphery in a CXCR3-
dependent manner (Figure 2d) [62,66,67]. CD8+ T cells
travel to the site of pathogen accumulation where they
become activated [66,68–70]. Furthermore, engagement
of memory CD8+ T cells with DCs triggers the release of
IFNg and CXCL9, promoting further mobilisation and
activation in a self-propagating feedback loop [66]. In
summary, chemokine guidance greatly increases the odds
of antigenic encounters by surveying T cells.
Concluding remarks
Significant progress has been made in the elucidation of
the mechanisms underlying T cell motility in the LN,
notably owing to advances in intravital imaging modal-
ities. Recent studies have revealed that optimal LN
scanning results from a combination of the intrinsic
migratory versatility of T cells, the local chemokine
milieu and the intricate microarchitecture of the LN.
The remarkable ability of T lymphocytes to switch from
one migration mode to another is underpinned by a
complex cross-talk of signalling pathways, of which the
small GTPases of the Rho and Rap family are central.
Targeting T cell navigation to curb pathological immune
disorders or to boost the host’s anti-tumour response
could constitute an attractive therapeutic target, as
indicated by emerging treatments based on the inhibition
of integrins [71], PI3K [72], Rho-GTPases [73], CTL-A
and PD-1 [74], all key regulators of T cell migration. The
next challenge, however, will be the complete mapping of
these signalling cascades, and a better understanding of
the variations in the regulation and function of these
pathways among different T cell subsets.
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